Ultrastructure of venous wall before and after the treatment with sclerosant

Authors

  • T.P. Segeda
  • V.A. Khodos
  • V.I. Zaritskaya

DOI:

https://doi.org/10.14739/2310-1237.2012.3.16993

Keywords:

varicose disease, phlebosclerotic obliteration, vein morphology, electron microscopy

Abstract

Basing upon results of ultrastructure studies of surgical specimens obtained from venous vessels after the use of sclerosant, it has been found out that the intensity of damage rises according to medicine  concentrations increase (2%, 3%, 5% respectively), and 3% concentration is optimal for the purposes of surgical fibrosclerosis.

References

Богачев В.Ю. Флебосклерозирующее лечение варикозной болезни вен нижних конечностей с использованием техники «foam-form» / Богачев В.Ю., Золотухин И.А., Брюшков А.Ю., Журавлева О.В. // Ангиология и сосудистая хирургия. – 2003. – Т. 9, №2. – С. 81–85.

Іркін І.В. Морфологічні зміни в стінці вени при мікропінній склерохірургії варикозної хвороби / Іркін І.В., Ходос В.А., Заріцька В.І. // Патологія. – 2012. – № 2 (25). – С. 79–83.

Суковатых Б.С. Способ лечения высокого вено-венозного рефлюкса при склеротерапии варикозной болезни нижних конечностей / Суковатых Б.С., Назаренко П.М., Беликов Л.Н., Родионов О.А. // Вестник хирургии. – 2002. – №2. – С.53–56.

Breu F.X. Результаты Европейской согласительной конференции по применению склерозирующих средств в виде пены при варикозном расширении вен нижних конечностей. Конгресс Международного союза флебологов / F.X. Breu, S. Guggenbichler, E. Rabe // Флеболимфология. – 2003. – №22. – С. 5.

Ceulen R.P. Outcomes and side effects of duplex-guided sclerotherapy in the treatment of great saphenous veins with 1% versus 3% Polidocanol form: results of randomised controlled trial with 1-year follow-up / Ceulen R.P, Bullens-Coessens Y.I, Pi-Van de Venne S.J. et al. // Dermatol Surg. – 2007. – №33. – P. 276–281.

Coleridge-Smith P. Chronic venous disease treated by ultrasound guided foam sclerotherapy / Coleridge-Smith P. // Eur. J. Vase. Endovasc. Surg. – 2006. – Vol. 32. – P. 577–583.

Rabe E. Efficacy and safety of great saphenous vein sclerotherapy using sten-dardised polidocanol foam (ESAF): a randomized controlled multicentre clinical trial / E. Rabe, J. Otto , D. Schiephake, F. Pannier // Eur J Vase Endovasc Surg. – 2008. – Vol. 35, №2. – P. 238–245.

Tessari L. Nouvelle technique d,obtentia de la sklero-mousse / Tessari L. // Phlebologie. – 2000. – Vol. 53. – P. 129–132.

Downloads

How to Cite

1.
Segeda T, Khodos V, Zaritskaya V. Ultrastructure of venous wall before and after the treatment with sclerosant. Pathologia [Internet]. 2013Aug.29 [cited 2024Nov.26];(3). Available from: http://pat.zsmu.edu.ua/article/view/16993

Issue

No. 3 (2012)

Section

Original research

License

Authors who publish with this journal agree to the following terms:

    1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
Лицензия Creative Commons
    1. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

  1. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (SeeThe Effect of Open Access).